GlassScriptPhysician profile
Denniz A Zolnoun
NPI 1447348750
$5,072.02
in general payments reported to CMS, 2019-2025
16 companies · $46.08 in 2025
The $46.08 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.68 · 2021: $4,987 · 2022: $14.29 · 2025: $46.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $46.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $46.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,711.00 | 2021 | |
| Abbvie INC. | $55.87 | 2021 | |
| Myovant Sciences INC. | $31.32 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $26.95 | 2021 | |
| Janssen Biotech, INC. | $26.25 | 2025 | Tremfya |
| Renovia INC | $25.99 | 2021 | |
| Boston Scientific Corporation | $24.68 | 2019 | |
| Exeltis, USA INC. | $24.25 | 2021 | |
| Merck Sharp & Dohme LLC | $21.76 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $19.83 | 2025 | Austedo Xr |
| Hologic Sales and Service, LLC | $19.70 | 2021 | |
| Minerva Surgical, INC | $19.55 | 2021 | |
| Agile Therapeutics, INC. | $17.76 | 2021 | |
| Coopersurgical, INC. | $16.57 | 2021 | |
| Evofem Biosciences, INC. | $15.64 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denniz Zolnoun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.